Latest News

Antibiotics, NSAIDs Reported Most Common Cause of Pediatric Anaphylaxis / image credit ©tashatuvango/stock.adobe.com
Antibiotics, NSAIDs Reported Most Common Cause of Pediatric Anaphylaxis

March 18th 2025

Among pediatric patients aged 1 month to 18 years with emergent anaphylaxis, cephalosporins were the leading antibiotics and ibuprofen the top NSAID implicated in a new study.

Epinephrine Nasal Spray Shows Rapid Symptom Relief in Children: Daily Dose / image credit: ©New Africa/AdobeStock
Epinephrine Nasal Spray Shows Rapid Symptom Relief in Children: Daily Dose

March 17th 2025

Dupilumab Cuts Food Allergy IgE Levels in Small Study: Daily Dose / image credit: ©New Africa/AdobeStock
Dupilumab Cuts Food Allergy IgE Levels in Small Study: Daily Dose

March 14th 2025

FDA Approves Neffy 1 mg Epinephrine Nasal Spray: Daily Dose / image credit: ©New Africa/AdobeStock
FDA Approves Neffy 1 mg Epinephrine Nasal Spray: Daily Dose

March 13th 2025

FDA Approves Omlyclo as First Interchangeable Omalizumab Biosimilar
FDA Approves Omlyclo as First Interchangeable Omalizumab Biosimilar

March 10th 2025

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.